Biography
Research Topics
Multi-Disciplinary Training Area
Lucas Ferrari de Andrade, PhD
ASSOCIATE PROFESSOR | Oncological Sciences
ASSOCIATE PROFESSOR | Oncological Sciences
Research
Natural Killer Cells and Cancer Immunotherapy
Natural killer cells, as the name implies, are lymphocytes that kill aberrant cells such as the ones that undergo malignant transformation. However, cancers often develop because of, at least in parts, mechanisms of immune evasion. Our laboratory develops antibodies that restore the immune surveillance for transformed cells. We reason that such antibodies could serve as immunotherapeutics for a variety of cancers. Visit the Ferrari de Andrade Laboratory
Education
BSc / Lic, Universidade Federal do Parana
MSc, Universidade Federal do Parana
PhD, Universidade Federal do Parana
Visiting Student, QIMR Berghofer Medical Research Institute
Postdoc, Dana-Farber Cancer Institute
Office Locations
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Ferrari de Andrade during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Innate Pharma
- Cullinan Oncology, LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Ferrari de Andrade during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Innate Pharma
- Cullinan Oncology, LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.